Cargando…

Erratum to: Personalized Management of Pheochromocytoma and Paraganglioma

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905331/ https://www.ncbi.nlm.nih.gov/pubmed/34904637 http://dx.doi.org/10.1210/endrev/bnab044

Ejemplares similares

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma
Publicado: (2021)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
por: Mamilla, Divya, et al.
Publicado: (2019)

Update on Modern Management of Pheochromocytoma and Paraganglioma
por: Lenders, Jacques W. M., et al.
Publicado: (2017)

Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas
por: Fagundes, Gustavo F C, et al.
Publicado: (2022)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
por: Clifton-Bligh, Roderick J.
Publicado: (2023)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

Dopamine-Secreting Pheochromocytoma and Paraganglioma
por: Miyamoto, Shotaro, et al.
Publicado: (2021)

Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)

Characteristics of Pediatric Pheochromocytoma/paraganglioma
por: Sarathi, Vijaya
Publicado: (2017)

Review of Pediatric Pheochromocytoma and Paraganglioma
por: Bholah, Reshma, et al.
Publicado: (2017)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
por: Ku, Eu Jeong, et al.
Publicado: (2021)

Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas
por: Meijs, Anouk C, et al.
Publicado: (2021)

The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management
por: Lima, José Viana, et al.
Publicado: (2023)

Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas
por: Snezhkina, Anastasiya, et al.
Publicado: (2021)

Pheochromocytoma and Paraganglioma: Challenges and Opportunities in 2021
por: Takahashi, Katsutoshi
Publicado: (2021)

Mutational Profile of Metastatic Pheochromocytoma and Paraganglioma
por: Choi, Yun Mi, et al.
Publicado: (2021)

A spontaneous paraganglioma–pheochromocytoma syndrome
por: Toutounchi, Sadegh, et al.
Publicado: (2013)

Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches
por: Costa, Marcia Helena Soares, et al.
Publicado: (2015)

Paraganglioma or pheochromocytoma? A peculiar diagnosis
por: Marques, Ricardo Rodrigues, et al.
Publicado: (2018)

New insights on the pathogenesis of paraganglioma and pheochromocytoma
por: Kantorovich, Vitaly, et al.
Publicado: (2018)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
por: Canu, Letizia, et al.
Publicado: (2019)

Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
por: Cascón, Alberto, et al.
Publicado: (2019)

Molecular Alterations in Dog Pheochromocytomas and Paragangliomas
por: Korpershoek, Esther, et al.
Publicado: (2019)

Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
por: Y-Hassan, Shams, et al.
Publicado: (2019)

Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas
por: Y-Hassan, Shams, et al.
Publicado: (2020)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
por: Ceccato, Filippo, et al.
Publicado: (2023)

Secondary diabetes mellitus in pheochromocytomas and paragangliomas
por: Moustaki, Melpomeni, et al.
Publicado: (2023)

Erratum to: Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus Guidelines
por: Ruiz, J. G., et al.
Publicado: (2020)

Supportive Management of Patients with Advanced Pheochromocytomas and Paragangliomas Receiving PRRT
por: Tsang, Erica S., et al.
Publicado: (2021)

Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience
por: De Filpo, G., et al.
Publicado: (2021)

Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options
por: Eid, Michal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h07focnhdhhkmmmr82cs7nl54e